Many previous studies have shown that tumor‐infiltrating lymphocytes are key players in tumor immune surveillance.[41, 42] Therefore, the changes of intratumoral immune subsets (CD8+ T, CD4+ T, and Treg cells) were analyzed by flow cytometry. This evidence concerns the gene CD4 and neoplasm.